M. Spetea et al., IN-VITRO BINDING AND SIGNALING PROFILE OF THE NOVEL MU-OPIOID RECEPTOR AGONIST ENDOMORPHIN-2 IN RAT-BRAIN MEMBRANES, Biochemical and biophysical research communications (Print), 250(3), 1998, pp. 720-725
The recently discovered endogenous mu receptor selective endomorphin 2
was prepared in tritiated form by a catalytic dehalogenation method r
esulting in a specific radioactivity of 1.98 TBq/mmol (53.4 Ci/mmol),
and used for in vitro labelling of rat brain membranes. The binding wa
s saturable, stereospecific and of high affinity (K-d: 0.97 and 1.12 n
M based on kinetic and equilibrium binding studies, respectively). The
maximal number of binding sites (B-max) was found to be 114.8 fmol/mg
protein. [H-3]Endomorphin 2 was displaced by mu-receptor selective sp
ecific peptides and heterocyclic compounds with high affinity, whereas
kappa and delta receptor specific ligands were much less potent. The
K-i values of endomorphin 1 and 2 in inhibiting [H-3]naloxone binding
increased by 15-fold in the presence of 100 mM NaCl which indicates th
e agonist property of these peptides. Endomorphins stimulated [S-35]GT
P gamma S binding and inhibited adenylyl cyclase activity which also p
rovides evidence for the agonist character of endomorphins. (C) 1998 A
cademic Press.